GENE ONLINE|News &
May 17, 2013: Dr. Janet Rowley Received Albany Medical Center Prize in Medicine and Biomedical Research
On May 17, 2013, American geneticist Janet Rowley was awarded the Albany Medical Center Prize in Medicine and Biomedical Research which was an important indicator of being regarded for the Nobel Prize. Rowley’s award-winning study shown that chronic myeloid leukemia cells have abnormal recombination on it chromosome 22, which in turn produces Bcr-Abl mutant kinases. This study was the foundation of developing the first drug (Imatinib) for targeted therapy in the world.
Image Source
https://www.timesunion.com/local/article/Lowering-the-cost-of-saving-lives-4527098.php#photo-4645736
Author
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
